Ossotide sodium chloride injection is a pharmaceutical product designed to address a range of bone and joint conditions. Formulated with a combination of Ossotide and sodium chloride, this injection is intended to promote bone healing, regulate bone metabolism, and alleviate symptoms associated with inflammatory joint disorders. This article provides an in-depth analysis of the product's features, benefits, technical specifications, and the company behind it, Shijiazhuang Kunxiangda Technology Co., Ltd..
Product Overview
Ossotide sodium chloride injection is a sterile, colorless to slightly yellow liquid packaged in glass bottles. It contains 0.1g of Ossotide and 0.87g of sodium chloride per 100ml solution. The product is indicated for the treatment of proliferative bone and joint diseases, rheumatism, rheumatoid arthritis, and other conditions that require fracture healing and bone metabolism regulation. Its formulation ensures a balanced electrolyte environment while delivering active peptides that support bone health.
Learn more about Ossotide sodium chloride injection.
Key Features and Benefits
One of the standout features of Ossotide sodium chloride injection is its ability to stimulate osteoblast proliferation and promote new bone formation. This makes it particularly effective for patients recovering from fractures or suffering from osteoporosis. The product also exhibits anti-inflammatory and analgesic effects, which can help reduce pain and swelling associated with rheumatoid arthritis and other inflammatory conditions.
Another significant advantage is its regulation of calcium and phosphorus metabolism, which is crucial for maintaining bone density and strength. Additionally, the product's intravenous administration ensures rapid absorption and systemic delivery, making it a preferred choice for acute treatment scenarios.
Technical Specifications
| Parameter | Details |
|---|---|
| Volume | 100ml |
| Active Ingredients | Ossotide (0.1g), Sodium Chloride (0.87g) |
| Formulation | Colorless or slightly yellow clear liquid |
| Administration | Intravenous infusion |
| Dosage | 50ml–100ml once daily, 15–30 days per course |
| Storage Conditions | Sealed, stored in a cool and shady place |
| Shelf Life | 2 years |
| Packaging | 20 bottles/box (glass infusion bottles) |
Applications and Indications
Ossotide sodium chloride injection is primarily used for the treatment of proliferative bone and joint diseases, including rheumatism and rheumatoid arthritis. Its ability to regulate bone metabolism and enhance calcium deposition makes it a valuable therapeutic option for patients with osteoporosis or those recovering from fractures. The product is also beneficial for individuals experiencing joint inflammation and chronic pain due to degenerative joint conditions.
According to the National Institute of Standards and Technology (NIST), advancements in medical technology rely on precise measurements and standardized protocols. Ossotide sodium chloride injection aligns with these principles by providing a consistent and reliable formulation for clinical use. [1]
Safety and Precautions
While Ossotide sodium chloride injection is generally well-tolerated, it is important to note potential adverse reactions such as allergic responses (e.g., fever, rash, and hypotension). The product is contraindicated for individuals with severe renal insufficiency or known hypersensitivity to its components. Patients should also avoid using it concurrently with amino acid drugs or alkaline medications due to potential interactions.
Before administration, healthcare professionals must inspect the solution for turbidity or particulate matter. If any abnormalities are observed, the product should be discarded immediately. Pregnant and lactating women are advised to consult their physicians before use, as the product is contraindicated during pregnancy.
Company Background: Shijiazhuang Kunxiangda Technology Co., Ltd.
Shijiazhuang Kunxiangda Technology Co., Ltd., the manufacturer of Ossotide sodium chloride injection, is a reputable company based in Shijiazhuang, China. The company specializes in the development and distribution of pharmaceutical products and medical solutions tailored to address musculoskeletal and inflammatory conditions. With a commitment to quality assurance and innovative research, the company has established itself as a trusted name in the healthcare industry.
As highlighted by NIST, the integration of advanced manufacturing standards ensures the reliability and efficacy of medical products. Shijiazhuang Kunxiangda Technology Co., Ltd. adheres to these principles, ensuring that its products meet rigorous quality and safety benchmarks. [1]
Conclusion
Ossotide sodium chloride injection represents a significant advancement in the treatment of bone and joint disorders. Its unique formulation, combined with a well-defined dosage regimen, offers a reliable solution for patients seeking bone regeneration, pain relief, and metabolic regulation. The product's adherence to scientific standards and the company's dedication to innovation further reinforce its value in the medical field.
For more information about Shijiazhuang Kunxiangda Technology Co., Ltd. and its product offerings, visit the official website. Explore Ossotide sodium chloride injection to discover how it can benefit your health or medical practice.
References
[1] National Institute of Standards and Technology (NIST). "Driving Innovation." Retrieved from https://www.nist.gov/.